1
项与 CAR-NK-CD19 Cells(Beijing Boren Hospital) 相关的临床试验Safety and Efficacy of Anti-CD19 CAR-Engineered NK Cells for Relapsed/Refractory B-cell Malignancies: a Multi-center, Open-label, Single-arm Clinical Study
This study is a single arm, open and multi center exploratory clinical study to observe the safety and effectiveness of CAR NK-CD19 in participants with recurrent or refractory CD19 positive B-cell malignant tumors, and preliminarily evaluate the expansion of this product in vivo and the objective remission rate after administration.
100 项与 CAR-NK-CD19 Cells(Beijing Boren Hospital) 相关的临床结果
100 项与 CAR-NK-CD19 Cells(Beijing Boren Hospital) 相关的转化医学
100 项与 CAR-NK-CD19 Cells(Beijing Boren Hospital) 相关的专利(医药)
100 项与 CAR-NK-CD19 Cells(Beijing Boren Hospital) 相关的药物交易